跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial
Approved
STANDARD
BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
062d9dbc5e49e774
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
062d9dbc5e49e774
Product Name
BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial
Artg Id
310943
Artg Name
BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2020-01-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d7b8793076ab63690faac8d23312564d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/50c51a1d1857fd5406e2f3ac8424dcdd.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
062d9dbc5e49e774
Type
Standard
Back to TGA Approvals